Patent · US Active

Nanoparticles for use in immunogenic compositions

US9393215B2 · kind B2 · utility

1Cited by

9References

49Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Janet Wendorf · Redwood City, US
Manmohan Singh · Cary, US
Derek O'Hagan · Winchester, US

Key dates

Filing date	Dec 1, 2006
Grant date	Jul 19, 2016
Priority date	—
Expiry date	Mar 24, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are sterile-filtered lyophilized nanoparticle compositions which contain at least one biodegradable polymer, at least one surfactant, at least one cryoprotective agent and at least one antigen. Also disclosed are methods of making and using such compositions and kits supplying such compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.